Literature DB >> 1424132

A new case of IgE myeloma.

R L Alexander1, S T Roodman, P J Petruska, C C Tsai, C G Janney.   

Abstract

We report a case of IgE myeloma in a 78-year-old woman who presented with bone pain in the shoulder and hip and progressive weakness. Except for hypercalcemia, routine chemistry values were within normal limits. Hemoglobin was decreased and the leukocyte count slightly increased. Plasma cells were not observed in the peripheral blood. Serum protein electrophoresis showed a monoclonal protein in the beta-globulin fraction. Immunofixation confirmed the presence of an IgE kappa monoclonal protein. A bone marrow biopsy revealed an interstitial and nodular infiltration of abnormal plasma cells comprising 60% of nucleated cells present. Skeletal roentgenograms and bone scans of this patient showed osteolytic lesions and osteopenia of the thoracic and lumbar spine and osteolytic destruction of the right half of the sacrum. Flow-cytometric analysis of mononuclear cells isolated from peripheral blood showed that 15% of the lymphocytes bound IgE. Using cell-surface markers, we identified 45% of the IgE-positive cells as natural killer cells. Similar results have been found in other diseases marked by increased IgE. The clinical, radiological, and laboratory findings for this patient are compared with previously reported cases of IgE and other types of myeloma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1424132

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  Bortezomib plus melphalan and prednisone (VMP regimen) as the initial treatment for IgE multiple myeloma: a case study.

Authors:  Hiroyuki Sato; Yusuke Komiya; Shigeru Hoshino
Journal:  Int J Hematol       Date:  2014-03-28       Impact factor: 2.490

2.  Prozone effect of serum IgE levels in a case of plasma cell leukemia.

Authors:  Giampaolo Talamo; William Castellani; Nathan G Dolloff
Journal:  J Hematol Oncol       Date:  2010-09-10       Impact factor: 17.388

3.  IgE myeloma with elevated level of serum CA125.

Authors:  Man-Ling Wang; Qiang Huang; Tian-Xin Yang
Journal:  J Zhejiang Univ Sci B       Date:  2009-07       Impact factor: 3.066

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.